Skip to main content

Table 3 Multivariable analyses in the TMA cohort

From: The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation

Covariates OS
HR (95% CI) P
UCHL1 expression 0.738 (0.535–1.018) 0.064
Age (< >  18 months) 1.508 (0.548–4.155) 0.427
Stage (4, 4S vs 1, 2, 3) 1.619 (0.674–3.891) 0.281